Treatment of infections caused by carbapenemase-producing Enterobacterales
Keywords: 
Carbapenem resistant Enterobacterales
Carbapenemases
Issue Date: 
2022
ISSN: 
0214-3429
Note: 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Citation: 
Íñigo-Pestaña, M. (Melania Elena); del Pozo-León, J. (José Luis). "Treatment of infections caused by carbapenemase-producing Enterobacterales". Revista Española de Quimioterapia. 35 (Supl. 3), 2022, 46 - 50
Abstract
Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of carbapenem-resistant Enterobacterales has been reported. The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection. New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits.

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
141.89 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.